OK you got me CTSO will be at $53 next week I was just trying to get cheap shares. If CTSO is not at $10 next week you will need to pump more. LOOK at my posts OVER 7 YEARS . Yes we hit $15 and are we at $15 on near $15 now? so stop the mindless pumping. Cytosorb is a great product and has a great future but people need to realize this stock wont be at 200 this year or wake up to a $42 dollar offer next month.
Thanks It's nice to hear a little calm instead of pumping or bashing. IMO for any major PPS jump you will need to hear Fresenius say "we" will recommend this as SOC or good news from a cardiac partner that says the same. And of course any FDA approvals will make a world of difference. I am resigned to believe we will not see $10 unless that happens. I hope sales alone might do it but sales will have to increase considerably.
Your a long way off if ever from seeing $200 so lets be real. Until FDA approval you will have a hard time seeing $15-20 never mind $200. Now watch all the red thumbs for keeping it real but I can almost guaranty you that you will be lucky to see 15 by year end and that's with great sales news. Been here around 7 years so I know better than to dream of overnight riches.
So if its approved in Canada and it is not selling there must be a reason. I guess the Canadian's know something
duh1027 why stick around and complain? unless your shorting or day trading and if you are day trading than you have nothing to complain about.
If you get FDA approval and start selling 10 million a year ( which at $20,000+ a treatment it could happen) then you can jump on that fence post and crow all you want. As for me I will stick to CTSO's plan to conquer the world first and the FDA later. Plus at 1-2 thousand a treatment it's the common mans treatment not like the $20,000 billionaires club only treatment
That was the pump wait for the dump then you can buy more spectral Friday
Spectral ended Q4 2015 with a revenue of $ 715,000 and 2.41million for the year and had a burn rate of 3,130.000 for Q4 (Talk about lights out?) CTSO'S revenue for 2015 was 4,792.000 and has a much larger market potential. Spectral is ahead in it's chance of being approved by the FDA do to it's 6 year P111 trial and it has an estimated cost per patient of $20-30 thousand dollars. Were CTSO has an estimated cost of 2-5 thousand dollars per patient. GLTA GO SPECTRAL GO!!!!
I have read on the MB about insiders hold almost all the shares and yesterday Spectra had one of the highest volume days in a very long time. That leads me to believe insiders must be selling but why are they selling?
What date did they start selling? How many have they sold so far? How many filters was their initial order. Please respond after you finish posting with your other alias.